공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 마이크로어레이 바이오칩 시장(2020-2024년)

Global Microarray Biochips Market 2020-2024

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2020년 12월 상품 코드 981782
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 2,900,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,480,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,640,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,800,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 마이크로어레이 바이오칩 시장(2020-2024년) Global Microarray Biochips Market 2020-2024
발행일 : 2020년 12월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 마이크로어레이 바이오칩 시장 규모는 2020-2024년 102억 2000만 달러로 성장하며, 예측 기간 중 20%의 CAGR로 성장할 전망입니다.

시장은 협업 전략에 의한 시장 입지의 향상, 맞춤형 의료의 사용 증가에 의해 추진되고 있습니다.

세계의 마이크로어레이 바이오칩 시장을 조사했으며, 시장 구도 및 규모, Five Forces 분석, 용도별 시장 세분화, 고객 및 지역별 상황, 벤더 구도, 벤더 분석 등의 정보를 정리하여 전해드립니다.

목차

개요

시장 구도

시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 2019년 시장 규모
  • 시장 전망 : 2019-2024년 예측

Five Forces 분석

시장 세분화 : 용도별

  • 시장 세분화
  • 용도별 비교
  • Drug Discovery·개발 : 시장 규모와 예측(2019-2024년)
  • 진단·치료 : 시장 규모와 예측(2019-2024년)
  • 연구·소모품 : 시장 규모와 예측(2019-2024년)
  • 법의학 : 시장 규모와 예측(2019-2024년)
  • 기타 : 시장 규모와 예측(2019-2024년)
  • 용도별 시장 기회

고객 상황

지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2019-2024년)
  • 유럽 : 시장 규모와 예측(2019-2024년)
  • 아시아태평양 : 시장 규모와 예측(2019-2024년)
  • 기타 지역 : 시장 규모와 예측(2019-2024년)
  • 주요 국가
  • 지역별 시장 기회
  • 시장 추진력
  • 시장이 해결해야 할 과제
  • 시장 동향

벤더 구도

  • 벤더 구도
  • 창조적 파괴 상황
  • 경쟁 시나리오

벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • Illumina Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

부록

KSA 21.01.26

Technavio has been monitoring the microarray biochips market and it is poised to grow by $ 10.22 bn during 2020-2024 progressing at a CAGR of 20% during the forecast period. Our report on microarray biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in market presence with collaboration strategy and growing use of personalized medicines. In addition, increase in market presence with collaboration strategy is anticipated to boost the growth of the market as well.

The microarray biochips market analysis includes application segment and geographical landscapes.

Technavio's microarray biochips market is segmented as below:

By Application

  • Drug discovery & development
  • Diagnostics & treatments
  • Research & consumables
  • Forensic medicines
  • Others

By Geographical Landscapes

  • North America
  • Europe
  • APAC
  • ROW

This study identifies rising demand of microarray biochips in genomics and proteomics as one of the prime reasons driving the microarray biochips market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on microarray biochips market covers the following areas:

  • Microarray biochips market sizing
  • Microarray biochips market forecast
  • Microarray biochips market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microarray biochips market vendors that include Agilent Technologies Inc., BioChain Institute Inc., Bio-Rad Laboratories Inc., Cepheid Inc., Fluidigm Corp., General Electric Co., Illumina Inc., Merck KGaA, PerkinElmer Inc., and Thermo Fisher Scientific Inc.. Also, the microarray biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Drug discovery and development - Market size and forecast 2019-2024
  • Diagnostics and treatments - Market size and forecast 2019-2024
  • Research and consumables - Market size and forecast 2019-2024
  • Forensic medicines - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer Landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor Landscape
  • Landscape disruption
  • Competitive Scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • BioChain Institute Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Fluidigm Corp.
  • General Electric Co.
  • Illumina Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Application - Market share 2019-2024 (%)
  • 22: Comparison by Application
  • 23: Drug discovery and development - Market size and forecast 2019-2024 ($ million)
  • 24: Drug discovery and development - Year-over-year growth 2019-2024 (%)
  • 25: Diagnostics and treatments - Market size and forecast 2019-2024 ($ million)
  • 26: Diagnostics and treatments - Year-over-year growth 2019-2024 (%)
  • 27: Research and consumables - Market size and forecast 2019-2024 ($ million)
  • 28: Research and consumables - Year-over-year growth 2019-2024 (%)
  • 29: Forensic medicines - Market size and forecast 2019-2024 ($ million)
  • 30: Forensic medicines - Year-over-year growth 2019-2024 (%)
  • 31: Others - Market size and forecast 2019-2024 ($ million)
  • 32: Others - Year-over-year growth 2019-2024 (%)
  • 33: Market opportunity by Application
  • 34: Customer landscape
  • 35: Market share by geography 2019-2024 (%)
  • 36: Geographic comparison
  • 37: North America - Market size and forecast 2019-2024 ($ million)
  • 38: North America - Year-over-year growth 2019-2024 (%)
  • 39: Europe - Market size and forecast 2019-2024 ($ million)
  • 40: Europe - Year-over-year growth 2019-2024 (%)
  • 41: APAC - Market size and forecast 2019-2024 ($ million)
  • 42: APAC - Year-over-year growth 2019-2024 (%)
  • 43: ROW - Market size and forecast 2019-2024 ($ million)
  • 44: ROW - Year-over-year growth 2019-2024 (%)
  • 45: Key leading countries
  • 46: Market opportunity by geography ($ million)
  • 47: Impact of drivers and challenges
  • 48: Vendor landscape
  • 49: Landscape disruption
  • 50: Industry risks
  • 51: Vendors covered
  • 52: Market positioning of vendors
  • 53: Agilent Technologies Inc. - Overview
  • 54: Agilent Technologies Inc. - Business segments
  • 55: Agilent Technologies Inc. - Key offerings
  • 56: Agilent Technologies Inc. - Key customers
  • 57: Agilent Technologies Inc. - Segment focus
  • 58: BioChain Institute Inc. - Overview
  • 59: BioChain Institute Inc. - Product and service
  • 60: BioChain Institute Inc. - Key offerings
  • 61: BioChain Institute Inc. - Key customers
  • 62: BioChain Institute Inc. - Segment focus
  • 63: Bio-Rad Laboratories Inc. - Overview
  • 64: Bio-Rad Laboratories Inc. - Business segments
  • 65: Bio-Rad Laboratories Inc. - Key offerings
  • 66: Bio-Rad Laboratories Inc. - Key customers
  • 67: Bio-Rad Laboratories Inc. - Segment focus
  • 68: Cepheid Inc. - Overview
  • 69: Cepheid Inc. - Product and service
  • 70: Cepheid Inc. - Key offerings
  • 71: Cepheid Inc. - Key customers
  • 72: Cepheid Inc. - Segment focus
  • 73: Fluidigm Corp. - Overview
  • 74: Fluidigm Corp. - Business segments
  • 75: Fluidigm Corp. - Key offerings
  • 76: Fluidigm Corp. - Key customers
  • 77: Fluidigm Corp. - Segment focus
  • 78: General Electric Co. - Overview
  • 79: General Electric Co. - Business segments
  • 80: General Electric Co. - Key offerings
  • 81: General Electric Co. - Key customers
  • 82: General Electric Co. - Segment focus
  • 83: Illumina Inc. - Overview
  • 84: Illumina Inc. - Product and service
  • 85: Illumina Inc. - Key offerings
  • 86: Illumina Inc. - Key customers
  • 87: Illumina Inc. - Segment focus
  • 88: Merck KGaA - Overview
  • 89: Merck KGaA - Business segments
  • 90: Merck KGaA - Key offerings
  • 91: Merck KGaA - Key customers
  • 92: Merck KGaA - Segment focus
  • 93: PerkinElmer Inc. - Overview
  • 94: PerkinElmer Inc. - Business segments
  • 95: PerkinElmer Inc. - Key offerings
  • 96: PerkinElmer Inc. - Key customers
  • 97: PerkinElmer Inc. - Segment focus
  • 98: Thermo Fisher Scientific Inc. - Overview
  • 99: Thermo Fisher Scientific Inc. - Business segments
  • 100: Thermo Fisher Scientific Inc. - Key offerings
  • 101: Thermo Fisher Scientific Inc. - Key customers
  • 102: Thermo Fisher Scientific Inc. - Segment focus
  • 103: Currency conversion rates for US$
  • 104: Research Methodology
  • 105: Validation techniques employed for market sizing
  • 106: Information sources
  • 107: List of abbreviations
Back to Top
전화 문의
F A Q